Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 420 entries
View as:

Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02479945 Org: User:
Start: 01/31/12 End: 04/25/13 Due: 04/25/14

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05758688 Org: User:
Start: 11/06/23 End: 11/30/26 Due: 11/30/27

Healthy Volunteers Study

Phase: N/A Priority: Normal
NCT ID: NCT06962059 Org: User:
Start: 04/21/25 End: 05/25/26 Due: 05/25/27

Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03757689 Org: User:
Start: 05/06/19 End: 02/28/27 Due: 02/28/28

Shared Decision-making and Colorectal Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT04748380 Org: User:
Start: 01/18/23 End: 12/31/25 Due: 12/31/26

A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study

Phase: N/A Priority: Normal
NCT ID: NCT01736345 Org: User:
Start: 12/03/12 End: 11/30/15 Due: 11/30/16

Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02530008 Org: User:
Start: 10/31/13 End: 10/31/26 Due: 10/31/27

Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00948753 Org: User:
Start: 06/30/09 End: 04/30/11 Due: 04/30/12

Project PLUS Lung Cancer Screening Promotion

Phase: N/A Priority: Normal
NCT ID: NCT05937399 Org: User:
Start: 12/02/22 End: 12/31/24 Due: 12/31/25

Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention

Phase: N/A Priority: Normal
NCT ID: NCT05338307 Org: User:
Start: 05/13/22 End: 04/30/25 Due: 04/30/26

Genetics and Heart Health After Cancer Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03510689 Org: User:
Start: 12/05/17 End: 05/31/22 Due: 05/31/23

The Breast Program - Translational Cancer Resource

Phase: N/A Priority: Normal
NCT ID: NCT02798341 Org: User:
Start: 07/31/12 End: 07/31/30 Due: 07/31/31

Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches

Phase: N/A Priority: Normal
NCT ID: NCT04812795 Org: User:
Start: 09/08/21 End: 06/20/22 Due: 06/20/23

A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01839799 Org: User:
Start: 04/30/13 End: 07/31/17 Due: 07/31/18

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

Phase: N/A Priority: Normal
NCT ID: NCT02167360 Org: User:
Start: 06/30/16 End: - Due: -

FDG PET/CT in Lung Cancer Staging

Phase: N/A Priority: Normal
NCT ID: NCT02738398 Org: User:
Start: 04/30/16 End: 10/31/25 Due: 10/31/26

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00948935 Org: User:
Start: 04/30/09 End: 09/26/14 Due: 09/26/15

Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01018901 Org: User:
Start: 01/31/09 End: 12/31/13 Due: 12/31/14

A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01506973 Org: User:
Start: 12/31/11 End: 03/31/22 Due: 03/31/23

Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00909831 Org: User:
Start: 10/31/08 End: 11/30/13 Due: 11/30/14

Comparing Two Ways to Manage Head and Neck Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT05182229 Org: User:
Start: 03/11/22 End: 11/30/26 Due: 11/30/27

The Effects of Radiation in Reconstructed Breasts

Phase: N/A Priority: Normal
NCT ID: NCT01292772 Org: User:
Start: 12/31/10 End: 05/05/19 Due: 05/05/20

Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02157831 Org: User:
Start: 07/31/05 End: 02/29/08 Due: 02/28/09

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00599989 Org: User:
Start: 01/31/05 End: 05/11/09 Due: 05/11/10

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01020292 Org: User:
Start: 04/30/09 End: 12/31/17 Due: 12/31/18